SYRA HEALTH CORP. Proceeds from Long-term Lines of Credit
SYRA HEALTH CORP. (SYRA) reported Proceeds from Long-term Lines of Credit of $300.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-11.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromLongTermLinesOfCredit · last filed 2025-03-11
- SYRA HEALTH CORP. proceeds from long-term lines of credit for the quarter ending 2023-12-31 was $0.00, a 100.00% decline year-over-year.
- SYRA HEALTH CORP. proceeds from long-term lines of credit for the quarter ending 2023-09-30 was $0.00.
- SYRA HEALTH CORP. proceeds from long-term lines of credit for the quarter ending 2023-06-30 was $0.00.
- SYRA HEALTH CORP. proceeds from long-term lines of credit for the quarter ending 2023-03-31 was $300.00K.
- SYRA HEALTH CORP. proceeds from long-term lines of credit for fiscal 2023 was $300.00K, a 89.36% decline from fiscal 2022.
- SYRA HEALTH CORP. proceeds from long-term lines of credit for fiscal 2022 was $2.82M.
| Period end | Proceeds from Long-term Lines of Credit 3 month | Proceeds from Long-term Lines of Credit 6 month | Proceeds from Long-term Lines of Credit 9 month | Proceeds from Long-term Lines of Credit 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $0.00 derived: sum of 2 quarters · filed 2025-03-11 | $0.00 derived: sum of 3 quarters · filed 2025-03-11 | $300.00K 10-K · filed 2025-03-11 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | $0.00 derived: sum of 2 quarters · filed 2024-10-29 | $300.00K 10-Q · filed 2024-10-29 | $1.80M derived: sum of 4 quarters · filed 2024-10-29 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $300.00K 10-Q · filed 2024-08-08 | $1.80M derived: sum of 3 quarters · filed 2024-08-08 | |
| 2023-03-31 | $300.00K 10-Q · filed 2024-05-09 | $1.80M derived: sum of 2 quarters · filed 2024-05-09 | ||
| 2022-12-31 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $2.82M 10-K · filed 2024-03-25 | ||
| 2022-09-30 | $1.32M 10-Q · filed 2023-11-14 |